Terra Tech Corp. announced this week that it’s subsidiary, Edible Garden, a retail seller of locally grown hydroponic produce, herbs, and floral products, has shipped its very first order of nutritionally-enhanced lettuce to ShopRite Supermarkets. More non-GMO products are a great sign of the times as people are getting reality checks on the major comparisons … Continue reading “Terra Tech Corp. (OTC: TRTC) Attacks ShopRite Stores With Killer Healthy Lettuce”
Biotech & Pharma
Biotech & Pharma
Innovus Pharmaceuticals (OTC: INNV) Grows Balls With Testosterone Supplement Acquisition
Innovus Pharmaceuticals got a dose of testosterone in its share price this week. The over-the-counter…
May 24, 2016
Biotech & PharmaHot Stocks
Best Buy (NYSE: BBY) Shares Plummet After It’s Peace Out For CFO
One would think that with first-quarter net income jumping more than 77% to $229 million,…
May 24, 2016
Biotech & PharmaLife
Chewbacca Mom Laughs All The Way To Hollywood
Love her or hate her, Chewbacca mom is here to stay... at least for now.…
May 24, 2016
Biotech & Pharma
Go Pro (NASDAQ: GPRO) Just Got Its Wings With Huge Red Bull Deal
Whether you have the camera strapped to your dog's head to see life from their…
May 24, 2016
Biotech & PharmaHot Stocks
Netflix (NASDAQ: NFLX) Gives Us Yet Another Reason To Stay Home On The Couch
In an an economy where most are cash strapped, Netflix has become the best friend…
May 24, 2016
Biotech & Pharma
Bill Cosby May Soon Pay The Piper As He Goes To Trial
Pudding pops may not have been the only popsicle treat that Bill Cosby was pitching…
May 24, 2016
Biotech & PharmaLife
FitBit (NYSE: FIT) Tracker Deemed Highly Innaccurate According To Studies
Fitbit's class action lawsuit may have just become more complicated as the company's heart rate…
May 23, 2016
Biotech & PharmaHot Stocks
Apple (Nasdaq: AAPL) Expands Capital Return Program
Tech Giant Apple has recently announced that the company will be expanding its capital return…
May 23, 2016
Biotech & Pharma
Carbylan Therapeutics, Inc. (NASDAQ: CBYL) Suspends Hydros-TA Clinical Development
Carbylan Therapeutics announced in April that it has suspended further clinical development of its Hydros-TA.…
May 23, 2016
Biotech & Pharma
22nd Century Group, Inc. (NYSE: XXII) Launches New Line of Research Cigarettes
Shares of 22nd Century Group Inc. (NYSE: XXII) saw a bump in share price on…
May 23, 2016